- Home
- BGLC vs SSY Comparison
BGLC vs SSY Comparison
Compare BGLC & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- SSY
- Stock Information
- Founded
- BGLC 2017
- SSY 1959
- Country
- BGLC Malaysia
- SSY United States
- Employees
- BGLC N/A
- SSY N/A
- Industry
- BGLC Medical Specialities
- SSY Hospital/Nursing Management
- Sector
- BGLC Health Care
- SSY Health Care
- Exchange
- BGLC Nasdaq
- SSY Nasdaq
- Market Cap
- BGLC 5.8M
- SSY 6.3M
- IPO Year
- BGLC N/A
- SSY N/A
- Fundamental
- Price
- BGLC $2.88
- SSY $0.90
- Analyst Decision
- BGLC
- SSY
- Analyst Count
- BGLC 0
- SSY 0
- Target Price
- BGLC N/A
- SSY N/A
- AVG Volume (30 Days)
- BGLC 1.8M
- SSY 12.6K
- Earning Date
- BGLC 04-15-2025
- SSY 05-14-2025
- Dividend Yield
- BGLC N/A
- SSY N/A
- EPS Growth
- BGLC N/A
- SSY N/A
- EPS
- BGLC N/A
- SSY 0.14
- Revenue
- BGLC $9,510,646.00
- SSY $31,233,000.00
- Revenue This Year
- BGLC N/A
- SSY N/A
- Revenue Next Year
- BGLC N/A
- SSY N/A
- P/E Ratio
- BGLC N/A
- SSY $6.20
- Revenue Growth
- BGLC N/A
- SSY N/A
- 52 Week Low
- BGLC $2.01
- SSY $0.53
- 52 Week High
- BGLC $8.40
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- BGLC 51.78
- SSY 46.62
- Support Level
- BGLC $2.47
- SSY $0.85
- Resistance Level
- BGLC $2.99
- SSY $0.98
- Average True Range (ATR)
- BGLC 0.49
- SSY 0.09
- MACD
- BGLC 0.07
- SSY -0.00
- Stochastic Oscillator
- BGLC 58.87
- SSY 53.61
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.